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Overview
Since the discovery of Helicobacter pylori, the urease activity of
this bacterial pathogen has been identified as the key factor in
infection and acid acclimation in the human stomach. Ureolytic
activity plays a key role in the pathogenesis of several bacteria, and
urease has also been described as an emerging pathogenic factor
during fungal infection. However, urease produced by the oral
bacteria community has been shown to counteract caries, and
caries-free subjects have high levels of urease activity in plaque
samples. Some lactic acid bacteria with documented probiotic
behavior are urease-positive. Likewise, other lactic acid bacterial
species that are widely used in yogurt production and other
fermented dairy products use urease activity to counteract acid
stress and to feed several biosynthetic pathways with carbon
dioxide and ammonia derived from urea hydrolysis. Urease is also
diffused in several species belonging to the human gut microbiota,
and it is estimated that this complex microbial community is able
to hydrolyze 15%–30% of the urea synthesized in normal subjects.
In this context, urease was proposed to serve as a microbial
biomarker to distinguish microbiomes based on age and geogra-
phy, thus highlighting the crucial involvement of this enzymatic
activity in nitrogen recycling when dietary nitrogen is limiting. In
light of these considerations, the designation of urease as a
microbial virulence factor would be misleading, and the proposed
use of urease as a therapeutic target to counteract microbial
infections should be carefully evaluated.
Urease: Multifunctional Roles in Microbial
Physiology
Urease and its substrate urea represent historically important
milestones in early scientific investigation. Urea was the first
organic molecule synthesized, and urease from jack bean was the
first enzyme crystallized, in addition to being the first enzyme
shown to contain nickel [1–4]. The scientific interest in microbial
urease is largely related to the relevance of this enzymatic activity
in infection. This interest has been strongly stimulated since the
discovery of the association of H. pylori with gastritis and stomach
cancer [5]. Moreover, urease has served as a paradigm for
understanding the activation mechanisms of many metalloen-
zymes that require accessory proteins for their catalytic activity
[3,4]. Urease is a urea amidohydrolase (EC 3.5.1.5) that catalyzes
the hydrolysis of urea to yield ammonia and carbamate, which
spontaneously decomposes to yield a second molecule of ammonia
and carbonic acid. The released carbonic acid and the two
molecules of ammonia are in equilibrium with their deprotonated
and protonated forms, respectively, and the net effect of these
reactions is an increase in the pH of the environment that
surrounds the urease-positive microorganisms (Fig. 1). For this
reason, urease is considered a stress response that was developed
by several bacteria to counteract a low environmental pH [6]. In
Streptococcus thermophilus, urease is metabolically related to the
biosynthetic pathways involved in aspartate, glutamine, arginine,
and carbon dioxide metabolism [7,8]. Notably, urea hydrolysis
increases the catabolic efficiency of S. thermophilus by modulating
the intracellular pH and increasing the activity of b-galactosidase,
glycolytic enzymes, and lactate dehydrogenase [9]. Urea hydro-
lysis results in increases in both the pHin and the pHout due to the
rapid diffusion of ammonia outside of the cell. Consequently, in
the presence of urea and a urease-positive microorganism, urease-
negative microorganisms share the environmental benefit derived
from the transient local pH increase [9].
Beyond that, the role of urease in most of the microorganisms
that show this enzymatic activity is primarily linked to the
recycling of nitrogenous wastes and nitrogen assimilation.
Human Microbiota Urease As a ‘‘Health-
Associated Factor’’
Urea is the major nitrogenous waste product of most
terrestrial animals. Ammonium, released from the urea present
in the secretions of major and minor exocrine glands, provides a
nitrogen source for bacteria that colonize the human body. It
was estimated that 15%–30% of the urea synthesized in healthy
subjects is continually hydrolyzed by microbial ureases [10].
Several microbial species belonging to the human microbiota
produce active urease, and these species take advantage of urea
hydrolysis, as has been demonstrated for the oral bacteria
Streptococcus salivarius [11] and Actinomyces naeslundii [12]
and hypothesized for other species of the gut microbiota
[13,14]. Urea is also present in human milk. Human milk
contains only approximately 15% of its nitrogen in the form of
urea. It is therefore believed that the total nitrogen in the infant
lower gastrointestinal tract (GIT) may be present at suboptimal
levels [15]. An increase in postnatal nitrogen levels is likely
necessary to satisfy the growth and metabolism requirements of
the infant and the GIT microbiota. In human infants, it has
been determined that the amino acids in plasma can be derived
from urea after hydrolysis and utilization of nitrogen by the
intestinal microbiota [16]. It is therefore not surprising that an
early colonizer of the GIT of humans, the Bifidobacterium
longum subsp. Infantis, produced an active urease [17]. By
contrast, in subjects with acute liver failure, the major clinical
problem is the development of hepatic encephalopathy (HE)
that is associated with high level of gut-derived ammonia. In this
scenario, the microbial gut community, especially urease-
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positive species such as Klebsiella spp. and Proteus spp., is an
important source of ammonia in humans in the pathogenesis of
HE [18]. Several clinical cases have suggested that the severity
of HE can be reduced by modulating the microbial gut
community using agents that lead to a normalization of gut
microbiota, such as rifaximin, lactulose, prebiotics, and
probiotics. However, even probiotics can be urease-positive.
Interestingly, a recent study performed using a murine model
reported that the administration of the probiotic urease-positive
Lactobacillus reuteri reduced the amount of urease activity in
the murine gut, presumably due to the suppression of fecal
bacteria [19]. Another bacterial species that is currently used as
a probiotic for the oropharyngeal tract is the urease-positive S.
salivarius strain K12 [20]. Following oral administration, strain
K12 can colonize the oral mucosae of infants and adults and
down-regulate the innate immune responses of human epithelial
cells. It is also active against S. pyogenes and safe and well
tolerated by the human host [21]. In a more general food
context, it is worth mentioning that yogurt consumption is
commonly associated with a health benefit by the consumers
[21], and one of the two species of the yogurt consortium, S.
thermophilus, is urease-positive [22]. S. thermophilus is widely
used in the manufacturing of dairy products, yogurt, fermented
milk, and cheeses, and as a consequence, over 1021 living cells
carrying active urease molecules are ingested annually by the
human population.
A recent study [14] focused on the characterization of gut
microbial communities in two human populations revealed that
urease gene frequency was significantly higher in Malawian and
Amerindian infant microbiomes and that it decreased with age in
these two populations, unlike in the United States, where it
remains low from infancy to adulthood. Considering that urease
has a crucial involvement in nitrogen recycling, particularly when
diets are deficient in protein, the ability of the microbiome to use
urea would presumably be advantageous to both microbes and
host.
Urea is secreted into all parts of the digestive tract starting from
the oral cavity. In saliva, urea is present at a concentration of 3–
10 mM, and it represents a relevant nitrogen source for several
species belonging to the oral microbiota, including S. salivarius, S.
vestibularis and Actinomyces naeslundii. A substantial body of
evidence is beginning to accumulate that indicates a direct
contribution of alkali generation in dental biofilms to the inhibition
of dental caries [23]. The development of dental caries is favored
by tooth demineralization that happens as a consequence of the
frequent acidification of dental biofilms and the subsequent
emergence of acidogenic and acid-tolerant microorganisms,
including mutans streptococci and Lactobacillus spp., which
Figure 1. Schematic representation of the reaction catalyzed by microbial urease and the involvement of these enzymes in micro-
physiology, human health, and disease.
doi:10.1371/journal.ppat.1004472.g001
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ferment dietary carbohydrates rapidly and lower the pH. The
increasing number of acid-tolerant microorganisms results in a
simultaneous decrease in the less acid-tolerant species that are
often associated with dental health [24]. Notably, bacteria
associated with dental health are able to use urea and/or arginine
to generate ammonia. Alkali production by these microorganisms
positively affects the balance between the remineralization and
demineralization of the tooth and may help prevent the emergence
of cariogenic microorganisms [25]. The real scenario is actually
more complex than it might appear. In fact, while the urease
activity associated with plaque seems to correlate with a decrease
in the incidence of caries, the urease activity associated with the
saliva had a significant effect on the risk of developing caries, and
this effect was not protective but instead promoted the develop-
ment of caries [26]. It therefore appears that the oral localization
of urease activity is fundamental in preventing caries. Interestingly,
in mice, the carcinogenicity of the plaque bacterium S. mutans
(naturally urease-negative) was dramatically reduced in a deriva-
tive recombinant strain of S. mutans that was able to produce an
active urease, thus suggesting that recombinant ureolytic bacteria
may be useful in promoting dental health [27].
Microbial Urease As a General ‘‘Virulence Factor’’
In addition to the positive aspects of microbial ureases in human
health, a consistent body of evidence has identified urease as a
virulence factor for several microbial pathogens (Fig. 1). In fact,
ureolytic activity has a key role in the pathogenesis of bacteria such
as Clostridium perfringens, Helicobacter pylori, Klebsiella pneu-
moniae, Proteus mirabilis, Salmonella spp., Staphylococcus sapro-
phyticus, Ureoplasma urealyticum, and Yersinia enterocolitica, and
such activity has been reported in diseases such as urolithiasis,
pyelonephritis, ammonia encephalopathy, HE, hepatic coma, and
gastroduodenal infections [4,28]. The role of urease in microbial
infection has been well established in H. pylori. Hydrolysis of urea
in the human stomach provides NH3 that is essential for acid
neutralization, enabling H. pylori to raise the pH in its
microenvironment and periplasm, thus maintaining the proton
motive force [28]. Moreover, the urea-dependent ammonia
production appears to be partially responsible for the gastric
mucosal injury found in association withH. pylori infection [29]. A
proton-gated channel, UreI, which regulates the uptake of urea
[4], is only active at acidic pH and therefore does not allow for the
transport of urea into the bacterial cell at neutral pH, thus
preventing lethal alkalinization of the cytoplasm [4]. Without this
mechanism, H. pylori is unable to develop the infection process in
the stomach [30,31]. Similarly, the urease activity allows the
survival to the gastric transit of Y. enterocolitica [32].
The role of urease activity in urinary tract infections and struvite
and carbonate apatite stones formation was described for P.
mirabilis and Sta. saprophyticus. The urease-dependent invasive
property of P. mirabilis was supported by in vitro observation and
by the use of urease-negative mutants. P. mirabilis defective in
urease exhibited in a mouse model an ID50 more than 1,000-fold
higher than the wild-type strain, and only the wild-type strain was
able to persist significantly [33]. Likewise, the contribution of
urease to the cytopathogenicity of Sta. saprophyticus has been
demonstrated in a rat model using a chemically mutagenized
urease-deficient strain, and by the heterologous expression of an
active urease in the nonureolytic Staphylococcus carnosus strain
[34,35].
More recently [36], the role of urease as a general microbial
virulence factor was proposed, highlighting the emerging patho-
genic roles of urease during infection of the fungal species
Cryptococcus neoformans (a basidiomycete) and Coccidioides
posadasii (an ascomycete). During fungal lung infection, the urea
present in the epithelial lining fluid of the lungs is hydrolyzed by
fungal urease, and the generated ammonia inhibits immune
function and contributes to lung tissue damage [36].
Other human pathogens are urease-positive, and in many cases,
urea hydrolysis is thought to have a role in the infectivity or
persistence of the microorganisms. In this context, although largely
unexplored, the positive role of urease in microbial physiology
(Fig. 1) can be an advantage for a pathogen during the various
stages of the infection process in terms of competition with
commensal microorganisms associated with the human body.
Perspectives
Because of the facts that the human genome does not contain
urease-encoding genes and that no human nickel-containing
enzymes are known, urease was proposed as a potential
therapeutic target [36] without taking into consideration all the
positive aspects linked to the microbial ureases of the human
microbiota. In this context, the use of the term ‘‘virulence factor’’
for microbial ureases should be carefully evaluated. Microbiolo-
gists working on infectious organisms routinely define any gene
product that contribute to the virulence potential of a pathogen as
a ‘‘virulence factor.’’ Recently, the increasing interest in the
human microbiota raises questions about the terminology we use
to describe the molecular and metabolic strategies that pathogenic
microbes use to compete in these complex biological systems [37].
In the GIT, many pathogens and commensals use similar
strategies to overcome the challenges associated with this
particular environment. It would therefore be misleading to
describe the same strategies and structures found in harmless or
beneficial commensals as ‘‘virulence factors’’ simply because they
were acquired or evolved to survive in the GIT. The term ‘‘niche
factors’’ was therefore proposed [37] to describe the molecular and
metabolic strategies evolved by beneficial gut microbes to colonize
this complex environment.
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